Merck (MRK) Change in Cash (2009 - 2026)

Merck has disclosed Change in Cash across 18 years of filings, most recently posting -$9.3 billion for Q1 2026.

• In Q1 2026, Change in Cash fell 102.62% year-over-year to -$9.3 billion; the TTM figure through Mar 2026 stood at -$3.3 billion (down 208.92% YoY), while the FY2025 annual figure was $1.4 billion, down 78.59% from the prior year.
• Change in Cash declined to -$9.3 billion in Q1 2026, from -$3.6 billion in the prior quarter.
• Over the last five years, Change in Cash for MRK reached as high as $10.2 billion in Q3 2025 and fell as low as -$9.3 billion in Q1 2026.
• The 5-year median for Change in Cash is -$659.0 million (2025), against an average of -$162.9 million.
• Annual changes were most pronounced in 2023 — Change in Cash tumbled 768.23% — and 2024, when it surged 239.96%.
• A 5-year view of Change in Cash shows it stood at $1.5 billion in 2022, then tumbled by 217.8% to -$1.8 billion in 2023, then increased by 22.16% to -$1.4 billion in 2024, then tumbled by 160.58% to -$3.6 billion in 2025, then tumbled by 160.28% to -$9.3 billion in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$9.3 billion, -$3.6 billion, and $10.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.